1. Home
  2. MDXG vs UCTT Comparison

MDXG vs UCTT Comparison

Compare MDXG & UCTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • UCTT
  • Stock Information
  • Founded
  • MDXG 2006
  • UCTT 1991
  • Country
  • MDXG United States
  • UCTT United States
  • Employees
  • MDXG N/A
  • UCTT N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • UCTT Semiconductors
  • Sector
  • MDXG Health Care
  • UCTT Technology
  • Exchange
  • MDXG Nasdaq
  • UCTT Nasdaq
  • Market Cap
  • MDXG 1.1B
  • UCTT 1.1B
  • IPO Year
  • MDXG N/A
  • UCTT 2004
  • Fundamental
  • Price
  • MDXG $6.94
  • UCTT $25.91
  • Analyst Decision
  • MDXG Buy
  • UCTT Strong Buy
  • Analyst Count
  • MDXG 1
  • UCTT 3
  • Target Price
  • MDXG $12.00
  • UCTT $39.00
  • AVG Volume (30 Days)
  • MDXG 439.7K
  • UCTT 298.8K
  • Earning Date
  • MDXG 10-29-2025
  • UCTT 10-27-2025
  • Dividend Yield
  • MDXG N/A
  • UCTT N/A
  • EPS Growth
  • MDXG N/A
  • UCTT N/A
  • EPS
  • MDXG 0.21
  • UCTT N/A
  • Revenue
  • MDXG $363,774,000.00
  • UCTT $2,141,100,000.00
  • Revenue This Year
  • MDXG $12.68
  • UCTT N/A
  • Revenue Next Year
  • MDXG $8.18
  • UCTT $4.45
  • P/E Ratio
  • MDXG $32.78
  • UCTT N/A
  • Revenue Growth
  • MDXG 6.85
  • UCTT 14.28
  • 52 Week Low
  • MDXG $5.47
  • UCTT $16.66
  • 52 Week High
  • MDXG $10.14
  • UCTT $41.90
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 46.17
  • UCTT 62.95
  • Support Level
  • MDXG $6.89
  • UCTT $23.53
  • Resistance Level
  • MDXG $7.14
  • UCTT $25.82
  • Average True Range (ATR)
  • MDXG 0.18
  • UCTT 0.88
  • MACD
  • MDXG -0.04
  • UCTT 0.20
  • Stochastic Oscillator
  • MDXG 29.55
  • UCTT 78.56

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About UCTT Ultra Clean Holdings Inc.

Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments Products and Services. Its principal markets are Americas, Asia Pacific and EMEA.

Share on Social Networks: